Jarred Mitchell Griffin

Jarred Mitchell Griffin

Auto-generated profile, based on publicly available information

Jarred Mitchell Griffin

Cure Programme, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2020 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
JGJarred M Griffin
Jarred M Griffin
FBFrank Bradke
Frank Bradke
The recent years saw the advent of promising preclinical strategies that combat the devastating effects of a spinal cord injury (SCI) that are progressing towards clinical trials. However, individually, these treatments produce only modest levels of recovery in animal models of SCI that could hamper their implementation into therapeutic strategies in spinal cord injured humans. Combinational strategies have demonstrated greater beneficial outcomes than their individual components alone by addressing multiple aspects of SCI pathology. Clinical trial designs in the future will eventually also need to align with this notion. The scenario will become increasingly complex as this happens and conversations between basic researchers and clinicians are required to ensure accurate study designs and functional readouts.

8 April 2019 in Gene Therapy
Verified
Journal Article
Open access
PDF file
JGJarred M. Griffin
Jarred M. Griffin
BFBarbara Fackelmeier
Barbara Fackelmeier
DFDahna M. Fong
Dahna M. Fong
AMAlexander Mouravlev
Alexander Mouravlev
DYDeborah Young
Deborah Young
Simon O'CarrollSimon O'Carroll
Simon O'Carroll
Adeno-associated viral (AAV) vectors are a promising system for transgene delivery into the central nervous system (CNS) based on their safety profile and long-term gene expression. Gene delivery to the CNS has largely been neuron centric but advances in AAV technology are facilitating the development of approaches to enable transduction of glial cells. Considering the role of astrocytes in the on-going secondary damage in spinal cord injury (SCI), an AAV vector that targets astrocytes could show benefit as a potential treatment. Transduction efficiency, transgene expression and cellular tropism were compared for the AAV serotypes AAV5, AAV9 and AAVRec2 whereby destabilised yellow fluorescent protein (dYFP) was controlled by the GFAP or the truncated GfaABC1D promoter. The vectors were tested in primary spinal cord astrocyte cell culture, spinal cord slice culture and an in vivo model of SCI contusion. AAV5 resulted in greater transduction efficiency, transgene expression and astrocyte tropism compared with AAV9 and AAVRec2. In a rodent model of SCI, robust transgene expression by AAV5-GFAP/GfaABC1D-dYFP was observed through 12 mm of spinal cord tissue and expression was largely restricted to astrocytes. Thus, AAV5-GFAP/GfaABC1D carries the potential as a potential gene therapy vector, particularly for transducing astrocytes in the damaged spinal cord.

20 August 2024 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
BHBrett Hilton
Brett Hilton
JGJarred M. Griffin
Jarred M. Griffin
JFJames W Fawcett
James W Fawcett
FBFrank Bradke
Frank Bradke

1 October 2017 in Neurotherapeutics
Verified
Journal Article
Closed access
PDF file
YKYeri Kim
Yeri Kim
JGJarred M. Griffin
Jarred M. Griffin
MNMohd Nasir Mat Nor
Mohd Nasir Mat Nor
JZJie Zhang
Jie Zhang
PFPeter S. Freestone
Peter S. Freestone
CGColin R. Green
Colin R. Green

1 February 2017 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
YKYeri Kim
Yeri Kim
JGJarred M. Griffin
Jarred M. Griffin
PHPaul W.R. Harris
Paul W.R. Harris
SCSin Hang Crystal Chan
Sin Hang Crystal Chan
LNLouise F.B. Nicholson
Louise F.B. Nicholson
CGColin R. Green
Colin R. Green

1 May 2020 in Experimental Neurology
Verified
Journal Article
Closed access
JGJarred M. Griffin
Jarred M. Griffin
BFBarbara Fackelmeier
Barbara Fackelmeier
CCConnor A. Clemett
Connor A. Clemett
DFDahna M. Fong
Dahna M. Fong
AMAlexandre Mouravlev
Alexandre Mouravlev
Simon O'CarrollSimon O'Carroll
Simon O'Carroll